Research Solutions, Inc.
Business
Research Solutions, Inc. is a vertical SaaS and AI company that provides software and services to simplify research workflows for research-intensive organizations. It offers cloud-based Platforms for discovery, access, and management of scientific, technical and medical (STM) content, including AI-based assistants, article procurement, rights and permissions, and reference management. Key business divisions include Reprints Desk’s Article Galaxy access and document delivery services, Scite and Resolute discovery and analytics tools, and a References management solution. The Company sells primarily to corporate, academic, government and individual researchers via cloud subscriptions, APIs and transactional article sales.
Summary from filing dated 2025-09-19
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Total revenue | 49 | 45 | 38 | 33 | 32 | |
| Total cost of revenue | 25 | 25 | 23 | 21 | 21 | |
| Gross profit | 24 | 20 | 15 | 12 | 10 | |
| Selling, general and administrative | 20 | 20 | 14 | 14 | 11 | |
| Depreciation and amortization | 1 | 836,271 | 52,649 | 17,651 | 11,522 | |
| Total operating expenses | 22 | 20 | 14 | 14 | 11 | |
| Income (loss) from operations | 3 | −769,543 | 238,608 | −2 | −283,032 | |
| Other income | 595,679 | 333,088 | 338,617 | 7,154 | 1,147 | |
| Change in fair value of contingent earnout liability | −2 | −3 | 0 | — | — | |
| Income (loss) before provision for income taxes | 1 | −4 | 577,225 | −2 | −281,885 | |
| Provision for income taxes | −82,811 | −113,071 | −5,602 | −7,622 | −3,204 | |
| Net income (loss) | 1 | −4 | 571,623 | −2 | −285,089 | |
| Foreign currency translation | −1,368 | −595 | 3,717 | −2,364 | 5,461 | |
| Comprehensive income (loss) | 1 | −4 | 575,340 | −2 | −279,628 | |
| Net income (loss) per share (in dollars per share) | 0.04 | −0.13 | 0.02 | −0.06 | — | |
| Weighted average common shares outstanding | 31 | 29 | 27 | 26 | — | |
| Net income (loss) per share (in dollars per share) | 0.04 | −0.13 | 0.02 | −0.06 | — | |
| Weighted average common shares outstanding | 32 | 29 | 29 | 26 | — |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 12 | 6 | 14 | 11 | 11 | |
| Accounts receivable, net of allowance of $182,324 and $68,579, respectively | 7 | 7 | 6 | 5 | 5 | |
| Prepaid expenses and other current assets | 580,257 | 643,553 | 400,340 | 276,026 | 270,252 | |
| Prepaid royalties | 925 | 1 | 1 | 846,652 | 904,921 | |
| Total current assets | 20 | 15 | 21 | 17 | 17 | |
| Property and equipment, net of accumulated depreciation of $964,883 and $922,558, respectively | 60,769 | 88,011 | 70,193 | 47,985 | 20,755 | |
| Intangible assets, net of accumulated amortization of $2,736,773 and $1,535,310, respectively | 10 | 11 | 462,068 | 0 | — | |
| Goodwill | 16 | 16 | 0 | — | — | |
| Deposits and other assets | 957 | 981 | 1,052 | 893 | 906 | |
| Total assets | 46 | 42 | 22 | 17 | 17 | |
| Accounts payable and accrued expenses | 7 | 9 | 8 | 7 | 7 | |
| Deferred revenue | 11 | 9 | 6 | 6 | 5 | |
| Contingent earnout liability, current portion | 7 | 0 | — | — | — | |
| Total current liabilities | 26 | 18 | 15 | 12 | 11 | |
| Contingent earnout liability, long-term portion | 7 | 12 | 0 | — | — | |
| Total liabilities | 32 | 30 | 15 | — | — | |
| Commitments and contingencies | — | — | — | — | — | |
| Preferred stock; $0.001 par value; 20,000,000 shares authorized; no shares issued and outstanding | 0 | 0 | 0 | 0 | 0 | |
| Common stock; $0.001 par value; 100,000,000 shares authorized; 32,479,993 and 32,295,373 shares issued and outstanding, respectively | 32,480 | 32,295 | 29,487 | 27,076 | 26,498 | |
| Additional paid-in capital | 39 | 38 | 30 | 28 | 27 | |
| Accumulated deficit | −25 | −26 | −23 | −23 | −21 | |
| Accumulated other comprehensive loss | −120,187 | −118,819 | −118,224 | −121,941 | −119,577 | |
| Total stockholders' equity | 14 | 12 | 7 | 5 | 5 | |
| Total liabilities and stockholders' equity | 46 | 42 | 22 | 17 | 17 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-06-30 | FY 2024 2024-06-30 | FY 2023 2023-06-30 | FY 2022 2022-06-30 | FY 2021 2021-06-30 |
|---|---|---|---|---|---|---|
| Depreciation and amortization | 1 | 836,271 | 52,649 | 17,651 | 11,522 | |
| Stock options expense | 205,457 | 140,150 | — | — | — | |
| Restricted common stock expense | 2 | 2 | 1 | 557,496 | 376,338 | |
| Modification cost of accelerated vesting of restricted common stock | 0 | 20,949 | 56,000 | — | — | |
| Accounts receivable | −341,434 | −344,020 | −901,518 | −534,092 | −268,193 | |
| Prepaid expenses and other current assets | 63,296 | −164,579 | −124,314 | −5,774 | −28,505 | |
| Prepaid royalties | 1 | 135,441 | −356,026 | 58,269 | −184,554 | |
| Accounts payable and accrued expenses | −1 | 560,027 | 1 | −83,156 | 337,343 | |
| Deferred revenue | 2 | 921,879 | 886,198 | 734,175 | 1 | |
| Net cash provided by operating activities | 7 | 4 | 3 | −417,200 | 2 | |
| Purchase of property and equipment | −19,261 | −71,510 | −47,209 | −44,288 | −19,854 | |
| Net cash used in investing activities | −19,261 | −10 | −344,659 | −44,288 | −19,854 | |
| Proceeds from the exercise of stock options | 180,800 | 0 | 57,500 | 97,688 | 88,850 | |
| Common stock repurchase | −934,577 | −554,202 | −104,250 | −93,918 | −178,012 | |
| Payment of contingent acquisition consideration | −124,107 | −351,649 | −50,509 | 0 | — | |
| Net cash used in financing activities | −877,884 | −905,851 | −97,259 | 63,270 | −159,974 | |
| Effect of exchange rate changes | 1,260 | 4,851 | 229 | −2,944 | 4,203 | |
| Net increase (decrease) in cash and cash equivalents | 6 | −7 | 3 | −401,162 | 2 | |
| Cash paid for income taxes | 82,811 | 113,071 | 5,602 | 7,622 | 3,204 | |
| Contingent consideration accrual on asset acquisition | 31,359 | 32,022 | 138,428 | 0 | — |